跳至主要内容
临床试验/JPRN-UMIN000017302
JPRN-UMIN000017302已完成2 期

Study about efficacy of Dexmedetomidine as a novel sedative agent during ESD for esophageal cancer - Efficacy of Dexmedetomidine during esophageal ESD

Department of Gastroenterology,Cancer Institute Hospital0 个研究点目标入组 65 人开始时间: 2015年4月28日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
65

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1 Uncontrollable hypertention 2 Uncontrollable heart disease or arrhythmia 3 Respiratory disease needed oxygen in rest 4 Unstable angina (newly occurred or worsened in these 3 weeks) or myocardial infarction within 6 months 5 Difficult to discontinue antithrombotic drugs during preoperative period 6 Severe infectious disease needed systemic treatment 7 Patients judged inappropriate by investigator or attending doctor

研究者

发起方
Department of Gastroenterology,Cancer Institute Hospital

相似试验